Product

GNR-069

Aliases

romiplostim

Name

Nplate

INN Name

romiplostim

FDA Approved

Yes

1 clinical trial

1 organization

1 indication

1 document

Indication

Immune Thrombocytopenic Purpura

Clinical trial

Multicenter Randomized Double-blind Comparative Study of Clinical Efficacy and Safety of GNR-069 (JSC "GENERIUM", Russia) and Nplate (Amgen Europe BV, The Netherlands) in Patients With Idiopathic Thrombocytopenic Purpura

Status: Completed, Estimated PCD: 2023-08-22

Document

DailyMed Label: Nplate

Organization